COVID-19 Update: Coronavirus Antibiotic Treatment May Further Increase Resistant Bacteria, Experts Say

Increasing evidence indicates that COVID-19 may postpone an additional second slow-motion pandemic. Coronavirus is a viral disease that does not depend on antibiotics, many the study Performance Almost all severe COVID-19 patients will get antibiotics.

(Photo: REUTERS / P. Ravikumar)
April 23, 2020, in Chennai, India, a man driving a rickshaw depicting a coronavirus at home during a national blockade to delay the spread of coronavirus disease (COVID-19) Raise awareness about.

It is a false attempt to cure oneself, followed by taking antibiotics on their own, or through a wide variety of people, or by the encouragement of surrounding researchers.

However, the global crisis of antibiotic resistance carried out by the World Health Organization Declared a global risk to public health In 2014, this important defense is a diminishing resource. However, this increase in resistance is occurring while the antibiotic pipeline is empty.

Also read: Superbug develops antibiotic resistance faster than we can catch up

Significant public health, economic risk

Further complications: If an increase in antibiotic resistance occurs, there is no capsule to solve the problem. Some companies went bankrupt because antibiotic producers have abandoned the market and resistance has significantly reduced the profitability of their products. There is a real risk that research on new antibiotics should be delayed for several years as the drug companies are trying to find a remedy for the coronavirus.

Kathy Torkington, director of the Pew Charitable Trust’s Antibiotic Resistance Project, Said Wired use of antibiotics everywhere causes resistance to develop everywhere.

She pointed out that more and more antibiotics are being used in this pandemic. “Other countries [are] Face the challenge of how to best deal with COVID-19 [since antibiotics] It’s being used more and more in the United States. “

A subtle sign of growing concern over this issue is that antibiotic resistance researchers in several countries have disagreed with the Guide over the past few months. The researchers say there is no coordinated campaign, but there is an organic expression of how trends worry them. Petition magazine, newspaper, Trade Publication, Non-profit organization website, And other individuals blog.

of United Nations, World Health Organization,and World Bank Recognize as a public health and economic disaster waiting for antibiotic resistance to collapse. British economist Jim O’Neill and his crew report Saying that more people will die in 2016 Drug-resistant infections than cancer By 2050.

If left unsolved, antibiotic resistance costs trillions of dollars to the healthcare system. More importantly, hundreds of thousands of lives are sacrificed.

Also read: Environmental Pollution Causes Antibiotic Resistance: Other Factors That Make Bacteria Drug Resistant

Lessons from antibiotic resistance

The current pandemic shows that despite all medical advances, the world remains highly vulnerable to infections that have no cure. But with sufficient motivation, the world has shown that it can make significant adjustments in a fast time frame.

While work on antibiotic resistance is being done around the world, McMaster University Institute of Infectious Diseases I said that there is a long road ahead.

Despite all efforts to inform policymakers and the general public about the crisis of antibiotic resistance and provide viable solutions, it remains low on the priority list of many jurisdictions. Moreover, research on antibiotic resistance Lack of funds Compared to other medical disciplines including cancer and heart disease.

Another major hurdle to antibiotic resistance reactions is the loss of interest by large pharmaceutical companies. Expensive medical testing and risk of drug resistance keeps products wasted Challenge For them to recover.

Fortunately, antibiotics are the best way to fight bacterial infections. Another rare and very successful technique that everyone can learn from the crisis is vaccination.

However, vaccines also challenge development and delivery in the face of continuous development. Hesitation. New treatment Immune booster, Natural antibody, And other predators all show promises. However, it is not in the early stages of development.

Ⓒ 2018 TECHTIMES.com All rights reserved. Do not copy without permission.